| Profiles RNS

Profile

MD, University of Zimbabwe
MBChB, University of Zimbabwe
MSc, University of London

Websites

	World Health Organization Profile
	LinkedIn
	ResearchGate

Research
Publications

BU Research

Evaluation of Novartis Access in Kenya - Scope of Work 6
04/01/2020 - 03/31/2021 (Multi-PI)
PI: Richard Laing, MBChB, MSc (CHDC) MD
Sandoz International GmbH

IFPMA SOW 2
04/01/2017 - 03/31/2020 (PI)
International Federation of Pharmaceutical Manufacturers Association

Novartis Access Initiative Task Order 4
11/01/2017 - 10/31/2019 (Multi-PI)
PI: Richard Laing, MBChB, MSc (CHDC) MD
Sandoz International GmbH

Novartis Access Initiative Task Order 3
10/01/2016 - 04/30/2018 (PI)
Sandoz International GmbH

Novartis Access Initiative Task Order 2
04/29/2016 - 02/28/2018 (PI)
Sandoz International GmbH

IFPMA SOW 1
08/01/2016 - 12/30/2017 (PI)
International Federation of Pharmaceutical Manufacturers Association

Novartis Access Initiative Task Order 1
12/01/2015 - 04/30/2017 (PI)
Sandoz International GmbH

Title

Yr	Title	Project-Sub Proj	Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Ashigbie PG, Laing RO, Wirtz VJ, Nkrumah N, Kemboi A, Nwokike J. Registration timelines of antiretroviral medicines in Ghana and Kenya. AIDS. 2020 06 01; 34(7):1093-1095.View Related Profiles.

Laing, Richard
Wirtz, Veronika

PMID: 32073445

Ashigbie PG, Rockers PC, Laing RO, Cabral HJ, Onyango MA, Buleti JPL, Wirtz VJ. Availability and prices of medicines for non-communicable diseases at health facilities and retail drug outlets in Kenya: a cross-sectional survey in eight counties. BMJ Open. 2020 05 15; 10(5):e035132.View Related Profiles.

Cabral, Howard
Onyango, Monica
Rockers, Peter
Laing, Richard
Wirtz, Veronika

PMID: 32414824; PMCID: PMC7232616; DOI: 10.1136/bmjopen-2019-035132;

Umeh CA, Rockers PC, Laing R, Wagh O, Wirtz VJ. Public reporting on pharmaceutical industry-led access programs: alignment with the WHO medicine programs evaluation checklist. J Pharm Policy Pract. 2020; 13:5.View Related Profiles.

Rockers, Peter
Laing, Richard
Wirtz, Veronika

PMID: 32226630; PMCID: PMC7098075; DOI: 10.1186/s40545-020-0204-z;

Umeh CA, Garcia-Gonzalez P, Tremblay D, Laing R. The survival of patients enrolled in a global direct-to-patient cancer medicine donation program: The Glivec International Patient Assistance Program (GIPAP). EClinicalMedicine. 2020 Feb; 19:100257. PMID: 32140674

Umeh CA, Rockers PC, Laing RO, Wagh O, Wirtz VJ. Pharmaceutical industry-led partnerships focused on addressing the global burden of non-communicable diseases: a review of Access Accelerated. Public Health. 2020 Apr; 181:73-79.View Related Profiles.

Rockers, Peter
Laing, Richard
Wirtz, Veronika

PMID: 31958672

Ball D, Ewen M, Laing R, Beran D. Insulin price components: case studies in six low/middle-income countries. BMJ Glob Health. 2019; 4(5):e001705. PMID: 31565414

Rockers PC, Laing RO, Scott N, Ashigbie P, Lucca EH, Umeh CA, Wirtz VJ. Evaluation of pharmaceutical industry-led access programmes: a standardised framework. BMJ Glob Health. 2019; 4(4):e001659.View Related Profiles.

Scott, Nancy
Rockers, Peter
Laing, Richard
Wirtz, Veronika

PMID: 31423348; PMCID: PMC6688691; DOI: 10.1136/bmjgh-2019-001659;

Ewen M, Joosse HJ, Beran D, Laing R. Insulin prices, availability and affordability in 13 low-income and middle-income countries. BMJ Glob Health. 2019; 4(3):e001410. PMID: 31263585

Beran D, Laing RO, Kaplan W, Knox R, Sharma A, Wirtz VJ, Frye J, Ewen M. A perspective on global access to insulin: a descriptive study of the market, trade flows and prices. Diabet Med. 2019 06; 36(6):726-733.View Related Profiles.

Laing, Richard
Wirtz, Veronika
Kaplan, Warren

PMID: 30888075; PMCID: PMC6593686; DOI: 10.1111/dme.13947;

Mpanza NM, Bradley H, Laing R. Reasons why insured consumers co-pay for medicines at retail pharmacies in Pretoria, South Africa. Afr J Prim Health Care Fam Med. 2019 Mar 27; 11(1):e1-e6. PMID: 31038333

Showing 10 of 103 results. Show More

Rockers PC, Laing RO, Ashigbie PG, Onyango MA, Mukiira CK, Wirtz VJ. Effect of Novartis Access on availability and price of non-communicable disease medicines in Kenya: a cluster-randomised controlled trial. Lancet Glob Health. 2019 04; 7(4):e492-e502.View Related Profiles.

Onyango, Monica
Rockers, Peter
Laing, Richard
Wirtz, Veronika

PMID: 30799142

Syed N, Rockers PC, Vian T, Onyango M, Laing RO, Wirtz VJ. Access to Antihypertensive Medicines at the Household Level: A Study From 8 Counties of Kenya. Glob Heart. 2018 12; 13(4):247-253.e5.View Related Profiles.

Onyango, Monica
Rockers, Peter
Laing, Richard
Vian, Taryn
Wirtz, Veronika

PMID: 30245176

Onyango MA, Vian T, Hirsch I, Salvi DD, Laing R, Rockers PC, Ashigbie PG, Wirtz VJ. Perceptions of Kenyan adults on access to medicines for non-communicable diseases: A qualitative study. PLoS One. 2018; 13(8):e0201917.View Related Profiles.

Onyango, Monica
Rockers, Peter
Laing, Richard
Vian, Taryn
Wirtz, Veronika

PMID: 30142218; PMCID: PMC6108464; DOI: 10.1371/journal.pone.0201917;

Mehrtash H, Laing R, Wirtz VJ. Comparative analysis of essential medicines for cardiovascular diseases in countries of the WHO Eastern Mediterranean Region. East Mediterr Health J. 2018 Jul 17; 24(5):427-434.View Related Profiles.

Laing, Richard
Wirtz, Veronika

PMID: 30043961

Rockers PC, Laing RO, Wirtz VJ. Equity in access to non-communicable disease medicines: a cross-sectional study in Kenya. BMJ Glob Health. 2018; 3(3):e000828.View Related Profiles.

Rockers, Peter
Laing, Richard
Wirtz, Veronika

PMID: 29989082; PMCID: PMC6035514; DOI: 10.1136/bmjgh-2018-000828;

Wirtz VJ, Turpin K, Laing RO, Mukiira CK, Rockers PC. Access to medicines for asthma, diabetes and hypertension in eight counties of Kenya. Trop Med Int Health. 2018 08; 23(8):879-885.View Related Profiles.

Rockers, Peter
Laing, Richard
Wirtz, Veronika

PMID: 29808960; DOI: 10.1111/tmi.13081;

Hailu S, Rockers PC, Vian T, Onyango M, Laing R,Wirtz VJ. Access to diabetes medicines at the household level in eight counties of Kenya. J Diabetol. 2018; (9):45-55.

Barakat D, Rockers PC, Vian T, Onyango MA, Laing RO, Wirtz VJ. Access to asthma medicines at the household level in eight counties of Kenya. Int J Tuberc Lung Dis. 2018 05 01; 22(5):585-590.View Related Profiles.

Onyango, Monica
Rockers, Peter
Laing, Richard
Vian, Taryn
Wirtz, Veronika

PMID: 29663966

Magadzire BP, Marchal B, Mathys T, Laing RO, Ward K. Analyzing implementation dynamics using theory-driven evaluation principles: lessons learnt from a South African centralized chronic dispensing model. BMC Health Serv Res. 2017 Dec 04; 17(Suppl 2):724. PMID: 29219098

Rockers PC, Wirtz VJ, Umeh CA, Swamy PM, Laing RO. Industry-Led Access-To-Medicines Initiatives In Low- And Middle-Income Countries: Strategies And Evidence. Health Aff (Millwood). 2017 Apr 01; 36(4):706-713.View Related Profiles.

Rockers, Peter
Laing, Richard
Wirtz, Veronika

PMID: 28373337; DOI: 10.1377/hlthaff.2016.1213;

Ewen M, Zweekhorst M, Regeer B, Laing R. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases. PLoS One. 2017; 12(2):e0171284. PMID: 28170413; DOI: 10.1371/journal.pone.0171284;

Ewen M, Kaplan W, Gedif T, Justin-Temu M, Vialle-Valentin C, Mirza Z, Regeer B, Zweekhorst M, Laing R. Prices and availability of locally produced and imported medicines in Ethiopia and Tanzania. J Pharm Policy Pract. 2017; 10:7.View Related Profiles.

Laing, Richard
Kaplan, Warren

PMID: 28116107; PMCID: PMC5242052; DOI: 10.1186/s40545-016-0095-1;

Rockers PC, Wirtz VJ, Vian T, Onyango MA, Ashigbie PG, Laing R. Study protocol for a cluster-randomised controlled trial of an NCD access to medicines initiative: evaluation of Novartis Access in Kenya. BMJ Open. 2016 Nov 25; 6(11):e013386.View Related Profiles.

Onyango, Monica
Rockers, Peter
Laing, Richard
Vian, Taryn
Wirtz, Veronika

PMID: 27888177; PMCID: PMC5168521; DOI: 10.1136/bmjopen-2016-013386;

Wirtz VJ, Kaplan WA, Kwan GF, Laing RO. Response by Wirtz et al to Letter Regarding Article, "Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries". Circulation. 2016 10 04; 134(14):e305-e306.View Related Profiles.

Kwan, Gene
Laing, Richard
Wirtz, Veronika
Kaplan, Warren

PMID: 27698055

Beran D, Ewen M, Laing R. Insulin in 2016: Challenge and constraints to access. Diabetes Res Clin Pract. 2016 Jul; 117:119-21. PMID: 27329030; DOI: 10.1016/j.diabres.2016.06.001;

Wirtz VJ, Kaplan WA, Kwan GF, Laing RO. Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries. Circulation. 2016 May 24; 133(21):2076-85.View Related Profiles.

Kwan, Gene
Laing, Richard
Wirtz, Veronika
Kaplan, Warren

PMID: 27217433; PMCID: PMC4880457; DOI: 10.1161/CIRCULATIONAHA.115.008722;

Sharma A, Rorden L, Ewen M, Laing R. Evaluating availability and price of essential medicines in Boston area (Massachusetts, USA) using WHO/HAI methodology. J Pharm Policy Pract. 2016; 9:12. PMID: 27054040; DOI: 10.1186/s40545-016-0059-5;

Beran D, Ewen M, Laing R. Constraints and challenges in access to insulin: a global perspective. Lancet Diabetes Endocrinol. 2016 Mar; 4(3):275-85. PMID: 26857998; DOI: 10.1016/S2213-8587(15)00521-5;

Kaplan W, Laing R, Ewen M, Beran D. Insulin patents and market exclusivities: unresolved issues. Lancet Diabetes Endocrinol. 2016 Feb; 4(2):98.View Related Profiles.

Laing, Richard
Kaplan, Warren

PMID: 26825233; DOI: 10.1016/S2213-8587(15)00496-9;

Hazel Bradley, Siraaj Adams, Ricardo Kettledas, Tania Mathys, Margaret von Zeil, Richard Laing. Innovations to improve access to and use of medicines for chronic conditions. South African Pharmacy Journal. 2016; 83(5):36-40.

Cañigueral-Vila N, Chen JC, Frenkel-Rorden L, Laing R. Improvements for international medicine donations: a review of the World Health Organization Guidelines for Medicine Donations, 3rd edition. J Pharm Policy Pract. 2015; 8:28. PMID: 26525948; PMCID: PMC4628229; DOI: 10.1186/s40545-015-0045-3;

Bradley H, Laing R. Access to medicines - overcoming the barriers. East Mediterr Health J. 2015 Sep 28; 21(8):553-4. PMID: 26446525

Bukhman G, Bavuma C, Gishoma C, Gupta N, Kwan GF, Laing R, Beran D. Endemic diabetes in the world's poorest people. Lancet Diabetes Endocrinol. 2015 Jun; 3(6):402-3.View Related Profiles.

Kwan, Gene
Laing, Richard

PMID: 26003752; DOI: 10.1016/S2213-8587(15)00138-2;

Bigdeli M, Laing R, Tomson G, Babar ZU. Medicines and universal health coverage: challenges and opportunities. J Pharm Policy Pract. 2015; 8(1):8. PMID: 25825675; PMCID: PMC4350289; DOI: 10.1186/s40545-015-0028-4;

Tobin, M. R., & Laing, R. Generic medicine: Boston University students’ perceptions and surprising lack of knowledge. Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector. 2015; 3-4(11):136-145. View Publication

Ewen M, Al Sakit M, Saadeh R, Laing R, Vialle-Valentin C, Seita A, Bunders J. Comparative assessment of medicine procurement prices in the United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA). J Pharm Policy Pract. 2014; 7(1):13. PMID: 25379183; PMCID: PMC4210580; DOI: 10.1186/2052-3211-7-13;

Leopold C, Mantel-Teeuwisse AK, Vogler S, Valkova S, de Joncheere K, Leufkens HG, Wagner AK, Ross-Degnan D, Laing R. Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries. Bull World Health Organ. 2014 Sep 1; 92(9):630-640D. PMID: 25378754; PMCID: PMC4208566; DOI: 10.2471/BLT.13.129114;

Leopold, C., Mantel-Teeuwisse, A., Vogler, S., Valkova, S., de Joncheere, K., Leufkens, B., ... & Laing, R. PHARMACEUTICAL POLICY ANALYSIS–A EUROPEAN PERSPECTIVE ON PRICING AND REIMBURSEMENT IN CHALLENGING TIMES. Impact of the recession on the pharmaceutical policy environment and medicines sales in eight European countries. 2014; 77.

Tafuri G, Stolk P, Trotta F, Putzeist M, Leufkens HG, Laing RO, De Allegri M. How do the EMA and FDA decide which anticancer drugs make it to the market? A comparative qualitative study on decision makers' views. Ann Oncol. 2014 Jan; 25(1):265-9. PMID: 24356637; DOI: 10.1093/annonc/mdt512;

Bigdeli M, Javadi D, Hoebert J, Laing R, Ranson K. Health policy and systems research in access to medicines: a prioritized agenda for low- and middle-income countries. Health Res Policy Syst. 2013; 11:37. PMID: 24124696; PMCID: PMC3854087; DOI: 10.1186/1478-4505-11-37;

Leopold C, Mantel-Teeuwisse AK, Vogler S, de Joncheere K, Laing RO, Leufkens HG. Is Europe still heading to a common price level for on-patent medicines? An exploratory study among 15 Western European countries. Health Policy. 2013 Oct; 112(3):209-16. PMID: 24060335; DOI: 10.1016/j.healthpol.2013.08.012;

Bigdeli M, Javadi D, Hoebert J, Laing R, Ranson K. Health policy and system research in access to medicines: a prioritized agenda for low and middle income countries. Health Research and Policy Systems. 2013.

Hoebert JM, van Dijk L, Mantel-Teeuwisse AK, Leufkens HG, Laing RO. National medicines policies - a review of the evolution and development processes. J Pharm Policy Pract. 2013; 6:5. PMID: 24764540; PMCID: PMC3987068; DOI: 10.1186/2052-3211-6-5;

Barber SL, Huang B, Santoso B, Laing R, Paris V, Wu C. The reform of the essential medicines system in China: a comprehensive approach to universal coverage. J Glob Health. 2013 Jun; 3(1):010303. PMID: 23826503; PMCID: PMC3700034; DOI: 10.7189/jogh.03.010303;

Björkhem-Bergman L, Andersén-Karlsson E, Laing R, Diogene E, Melien O, Jirlow M, Malmström RE, Vogler S, Godman B, Gustafsson LL. Interface management of pharmacotherapy. Joint hospital and primary care drug recommendations. Eur J Clin Pharmacol. 2013 May; 69 Suppl 1:73-8. PMID: 23640191; DOI: 10.1007/s00228-013-1497-5;

Leopold C, Mantel-Teeuwisse AK, Seyfang L, Vogler S, de Joncheere K, Laing RO, Leufkens H. Impact of external price referencing on medicine prices - a price comparison among 14 European countries. South Med Rev. 2012 Dec; 5(2):34-41. PMID: 23532710; PMCID: PMC3606937

Bigdeli M, Jacobs B, Tomson G, Laing R, Ghaffar A, Dujardin B, Van Damme W. Access to medicines from a health system perspective. Health Policy Plan. 2013 Oct; 28(7):692-704. PMID: 23174879; PMCID: PMC3794462; DOI: 10.1093/heapol/czs108;

Cameron A, Mantel-Teeuwisse AK, Leufkens HG, Laing RO. Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved? Value Health. 2012 Jul-Aug; 15(5):664-73. PMID: 22867775; DOI: 10.1016/j.jval.2012.04.004;

Leopold C, Vogler S, Mantel-Teeuwisse AK, de Joncheere K, Leufkens HG, Laing R. Differences in external price referencing in Europe: a descriptive overview. Health Policy. 2012 Jan; 104(1):50-60. PMID: 22014843; DOI: 10.1016/j.healthpol.2011.09.008;

Trotta F, Leufkens HG, Schellens JH, Laing R, Tafuri G. Evaluation of oncology drugs at the European Medicines Agency and US Food and Drug Administration: when differences have an impact on clinical practice. J Clin Oncol. 2011 Jun 1; 29(16):2266-72. PMID: 21537038; DOI: 10.1200/JCO.2010.34.1248;

Cameron A, Roubos I, Ewen M, Mantel-Teeuwisse AK, Leufkens HG, Laing RO. Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries. Bull World Health Organ. 2011 Jun 1; 89(6):412-21. PMID: 21673857; PMCID: PMC3099556; DOI: 10.2471/BLT.10.084327;

Hoebert JM, Mantel-Teeuwisse AK, van Dijk L, Laing RO, Leufkens HG. Quality and completeness of utilisation data on biological agents across European countries: tumour necrosis factor alpha inhibitors as a case study. Pharmacoepidemiol Drug Saf. 2011 Mar; 20(3):265-71. PMID: 21351308; DOI: 10.1002/pds.2093;

Perehudoff SK, Laing RO, Hogerzeil HV. Access to essential medicines in national constitutions. Bull World Health Organ. 2010 Nov 1; 88(11):800. PMID: 21076556; PMCID: PMC2971519

Niëns LM, Cameron A, Van de Poel E, Ewen M, Brouwer WB, Laing R. Quantifying the impoverishing effects of purchasing medicines: a cross-country comparison of the affordability of medicines in the developing world. PLoS Med. 2010; 7(8). PMID: 20824175; PMCID: PMC2930876; DOI: 10.1371/journal.pmed.1000333;

van Mourik MS, Cameron A, Ewen M, Laing RO. Availability, price and affordability of cardiovascular medicines: a comparison across 36 countries using WHO/HAI data. BMC Cardiovasc Disord. 2010; 10:25. PMID: 20534118; PMCID: PMC2898673; DOI: 10.1186/1471-2261-10-25;

Madden JM, Meza E, Ewen M, Laing RO, Stephens P, Ross-Degnan D. Measuring medicine prices in Peru: validation of key aspects of WHO/HAI survey methodology. Rev Panam Salud Publica. 2010 Apr; 27(4):291-9. PMID: 20512232

Ritz LS, Adam T, Laing R. A bibliometric study of publication patterns in access to medicines research in developing countries. South Med Rev. 2010 Feb; 3(1):2-6. PMID: 23093876; PMCID: PMC3471169

Chalker J, Wagner A, Tomson G, Laing R, Johnson K, Wahlström R, Ross-Degnan D. Urgent need for coordination in adopting standardized antiretroviral adherence performance indicators. J Acquir Immune Defic Syndr. 2010 Feb; 53(2):159-61. PMID: 19861899

Tafuri G, Leufkens HG, Laing R, Trotta F. Therapeutic indications in oncology: emerging features and regulatory dynamics. Eur J Cancer. 2010 Feb; 46(3):471-5. PMID: 20056536; DOI: 10.1016/j.ejca.2009.11.021;

Waning B, Maddix J, Tripodis Y, Laing R, Leufkens HG, Gokhale M. Towards equitable access to medicines for the rural poor: analyses of insurance claims reveal rural pharmacy initiative triggers price competition in Kyrgyzstan. Int J Equity Health. 2009; 8:43.View Related Profiles.

Waning, Brenda
Laing, Richard
Tripodis, Yorghos

PMID: 20003422; PMCID: PMC2803474; DOI: 10.1186/1475-9276-8-43;

Kotwani A, Ewen M, Dey D, Iyer S, Lakshmi PK, Patel A, Raman K, Singhal GL, Thawani V, Tripathi S, Laing R. Prices & availability of common medicines at six sites in India using a standard methodology. Indian J Med Res. 2007 May; 125(5):645-54. PMID: 17642500

Mendis S, Fukino K, Cameron A, Laing R, Filipe A, Khatib O, Leowski J, Ewen M. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bull World Health Organ. 2007 Apr; 85(4):279-88. PMID: 17546309; PMCID: PMC2636320

Laing R, Vrakking H, Fourie B. Quality and stability of TB medicines: let the buyer beware! Int J Tuberc Lung Dis. 2004 Sep; 8(9):1043-4. PMID: 15455587

Laing R. EQA for AFB smear microscopy manual. Int J Tuberc Lung Dis. 2004 Jul; 8(7):920; authors reply 920-1. PMID: 15260289

Kaplan WA, Laing R. Paying for pharmaceutical registration in developing countries. Health Policy Plan. 2003 Sep; 18(3):237-48.View Related Profiles.

Laing, Richard
Kaplan, Warren

PMID: 12917265

Laing R, Waning B, Gray A, Ford N, 't Hoen E. 25 years of the WHO essential medicines lists: progress and challenges. Lancet. 2003 May 17; 361(9370):1723-9.View Related Profiles.

Waning, Brenda
Laing, Richard

PMID: 12767751

Laing R. Whose interests does the World Trade Organization serve? Lancet. 2003 Apr 12; 361(9365):1297. PMID: 12699973; DOI: 10.1016/S0140-6736(03)12996-0;

Pavin M, Nurgozhin T, Hafner G, Yusufy F, Laing R. Prescribing practices of rural primary health care physicians in Uzbekistan. Trop Med Int Health. 2003 Feb; 8(2):182-90. PMID: 12581446

Trouiller P, Olliaro P, Torreele E, Orbinski J, Laing R, Ford N. Drug development for neglected diseases: a deficient market and a public-health policy failure. Lancet. 2002 Jun 22; 359(9324):2188-94. PMID: 12090998

Laing R, Hogerzeil H, Ross-Degnan D. Ten recommendations to improve use of medicines in developing countries. Health Policy Plan. 2001 Mar; 16(1):13-20. PMID: 11238425

Laing RO, McGoldrick KM. Tuberculosis drug issues: prices, fixed-dose combination products and second-line drugs. Int J Tuberc Lung Dis. 2000 Dec; 4(12 Suppl 2):S194-207. PMID: 11144553

Laing RO, McGoldrick KM. Tuberculosis drug issues: prices, fixed-dose combination products and second-line drugs [The Eddie O'Brien Lecture]. Int J Tuberc Lung Dis. 2000 Dec 01; 4(12):194-207. PMID: 29490823

Laing RO, Ross-Degnan DG. National drug policies. Lancet. 1995 Dec 9; 346(8989):1561-2. PMID: 7491072

Hogerzeil HV, Bimo, Ross-Degnan D, Laing RO, Ofori-Adjei D, Santoso B, Azad Chowdhury AK, Das AM, Kafle KK, Mabadeje AF, et al. Field tests for rational drug use in twelve developing countries. Lancet. 1993 Dec 4; 342(8884):1408-10. PMID: 7901689

Massele AY, Sayi J, Nsimba SE, Ofori-Adjei D, Laing RO. Knowledge and management of malaria in Dar es Salaam, Tanzania. East Afr Med J. 1993 Oct; 70(10):639-42. PMID: 8187661

Massele AY, Ofori-Adjei D, Laing RO. A study of prescribing patterns with special reference to drug use indicators in Dar es Salaam Region, Tanzania. Trop Doct. 1993 Jul; 23(3):104-7. PMID: 8356735

Laing RO, Todd CH. Postgraduate district hospital training in Zambia. Lancet. 1993 Apr 10; 341(8850):966. PMID: 8096305

Howard NJ, Laing RO. Changes in the World Health Organisation essential drug list. Lancet. 1991 Sep 21; 338(8769):743-5. PMID: 1679879

Laing RO. What Changes Behaviour?. Dialogue on Diarrhoea. 1991; 45:6.
Laing RO, Muziki S. Prescriber Training within Malawi Essential Drugs Program: Report of a Consultancy. World Health Organization. 1991.
Matamora MK, Lamboray JL, Laing R. Integration of AIDS program activities into national health systems. AIDS. 1991; 5(Suppl 1):S193-6.

Quick JD, Laing RO, Ross-Degnan DG. Intervention research to promote clinically effective and economically efficient use of pharmaceuticals: the International Network for Rational Use of Drugs. J Clin Epidemiol. 1991; 44 Suppl 2:57S-65S. PMID: 2045843

Laing RO, Pallangyo K. World Bank/World Health Organization Study. Background Study on "Alternative Approaches to Managing the Opportunistic Illnesses of HIV-Infected Persons: Costs and Burden on the Tanzanian Health Care System". 1990.

Laing RO. Rational drug use: an unsolved problem. Trop Doct. 1990 Jul; 20(3):101-3. PMID: 2219416

Laing RO. International Network for the Rational Use of Drugs (INRUD) Trop Doct. 1990 Jul; 20(3):133-4. PMID: 2219430

Laing RO. Guidelines for Making Rational Choices on Use of Drugs and Clinical Management within AIDS Prevention and Control Programmes, Prepared for World Health Organization/GPA. 1990.
Laing RO. The International Network for the Rational Use of Drugs (INRUD). Tropical Doctor. 1990; 20:133-134.
Laing RO, Ross-Degnan DG. Report on the Inaugural Meeting of the International Network for the Rational Use of Drugs. Soc. Admin. Pharm. 1990; 7(3):144-146.
Todd CH, Laing R, Marnagwanda CS, Mushonga N. Iodine Deficiency Disorders in Zimbabwe. No change in prevalence of endemic goitre in Wedza District as shown by school surveys carried out 18 years apart. Central African Journal of Medicine. 1989; 35(1):304-6.
Laing RO, Ruredzo R. Development and Dissemination of Training Materials in Zimbabwe. Journal of Health Policy and Planning. 1989; 4(3):229-234.
Laing RO. Involving the Hospital. Appropriate Technology for Health. 1988; 20.
Laing RO. The Zimbabwe Experience with the Essential Drugs Programme. Zimbabwe Science News. 1988; 22(3/4):45-46.
Laing RO, Pigott M. Health and Living Conditions for Plantations. IDS Bulletin, People in Plantations: Means or Ends. 1987; 18(2):23-29.
Bloom G, Laing RO. Doctors, Private Practice and Primary Health Care. Journal of Health Policy and Planning. 1986; 1(3):267-269.
Laing RO. Health and Health Services for Plantation Workers. Evaluation and Planning Centre Publication. 1986; (10).
Laing RO. Another Development in Health: A Zimbabwe Case Study. IFDA Dossier. 1986; (55):13-16.
Loewenson RD, Paxton J, Zanza, Laing RO. Community Health Status in a Small Urban Area in Zimbabwe. Central African Journal of Medicine. 1983; 29(7):135-138.
Laing RO. Nutrition Education: What are We Trying to Achieve?. Central African Journal of Medicine. 1982; 28:184-187.
Zengeya S, Sena A, Zanza J, Loewenson R, Laing RO. The Health Status of Mineworkers in Zimbabwe. Central African Journal of Medicine. 1982; 28(7):155-159.

Kutshwa J, Laing RO. Need to follow W.H.O. recommendations in treatment of rabid animal bites. Cent Afr J Med. 1981 May; 27(5):98. PMID: 7249076

Chikanza IC, Paxton D, Lowenson R, Laing RO. The Health Status of Farm Worker Communities. Central African Journal of Medicine. 1980; 27(5):88-91.

Laing RO. Three cases of poisoning by Boophane disticha. Cent Afr J Med. 1979 Dec; 25(12):265-6. PMID: 544032

Laing RO. Relapse in organo phosphate poisoning. Cent Afr J Med. 1979 Oct; 25(10):225-6. PMID: 519742

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 24 publications over 14 distinct years, with a maximum of 4 publications in 1990

Bar chart showing 24 publications over 14 distinct years, with a maximum of 4 publications in 1990

Year	Publications
1980	1
1982	2
1983	1
1986	3
1987	1
1988	2
1989	2
1990	4
1991	3
2013	1
2014	1
2015	1
2016	1
2018	1

Contact for Mentoring: